50 likes | 56 Views
U.S. Respiratory Syncytial Virus Vaccines Market
E N D
U.S. Market Study on Respiratory Syncytial Virus Vaccines: Upcoming Launch of Cost-effective Candidates to Drive Market Growth Report Id : PMRREP33.45 Category : Life Science & Healthcare ©2020 Persistence Market Research, All Rights Reserved
About Persistence Market Research Customized Research Persistence Market Research(Persistence Market Research) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. Persistence Market Research is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Syndicated Research Investment Research Social Media Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Website: www.persistencemarketresearch.com For sales queries or new topics email us on: sales@persistencemarketresearch.com
U.S. Market Study on Respiratory Syncytial Virus Vaccines: Upcoming Launch of Cost-effective Candidates to Drive Market Growth The U.S. respiratory syncytial virus vaccines market is predicted to be valued at US$ 320.3 Mn in 2022. In-depth industry analysis reveals that respiratory syncytial virus vaccine sales in the U.S. are expected to surge at 18.2% CAGR and reach a market valuation of US$ 1.7 Bn by the end of 2032. Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/33045
Market Segmentation Access Full Report @ https://www.persistencemarketresearch.com/market-research/us-respiratory-syncytial-virus-vaccines-market.asp